CARL
Carlsmed, Inc.
$16.05
-2.73%
2026-08-21
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Key Fundamentals
Forward P/E
-10.38
EPS (TTM)
$-2.34
ROE
-66.1%
Revenue Growth (YoY)
56.7%
Profit Margin
-57.4%
Debt/Equity
26.02
Price/Book
4.63
Market Cap
$391.0M
Avg Volume (10D)
157K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$17.23
60D Low
$9.48
Avg Volume
149K
Latest Close
$16.05
Get breakout alerts for CARL
Sign up for Breakout Scanner to receive daily notifications when CARL triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Carlsmed, Inc. (CARL) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors CARL daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. CARL operates in the Healthcare sector within the Health Information Services industry. Data is provided for informational purposes only and does not constitute financial advice.